- Institutional Review Board
- Institutional Animal Care and Use Committee
- Institutional Biosafety Committee
- Export Controls
- Responsible Conduct of Research
- Research Misconduct
The Institutional Biosafety Committee (IBC) is responsible for reviewing all research that involves the use of recombinant DNA in accord with the NIH Guidelines (NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules revised April 2016) and ensuring that the proposed activities comply with the federal regulations governing them.
Clemson University IBC reviews/approves the following research: